Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Devalingam Mahalingam 59
Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Testing effectiveness (Phase 2)UnknownNCT03662412
What this trial is testing

Study of Sirolimus in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Large-scale testing (Phase 3)UnknownNCT02854072
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Samsung Pharmaceutical Co., Ltd. 148
Not applicableUnknownNCT04273477
What this trial is testing

Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Early research (Phase 1)Looking for participantsNCT07364357
What this trial is testing

A Phase I Study of CREPT-618 in Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 13
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Large-scale testing (Phase 3)UnknownNCT03775395
What this trial is testing

HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 250
Large-scale testing (Phase 3)UnknownNCT02008422
What this trial is testing

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tang Xushan 120
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Testing effectiveness (Phase 2)UnknownNCT06078657
What this trial is testing

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)PD-1 Inhibitors
The First Affiliated Hospital of Zhengzhou University 46
Testing effectiveness (Phase 2)Study completedNCT02437656
What this trial is testing

Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Centre Oscar Lambret 60
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Large-scale testing (Phase 3)Active Not RecruitingNCT05771480
What this trial is testing

Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

Who this might be right for
Biliary Tract Cancer
AstraZeneca 142
Testing effectiveness (Phase 2)UnknownNCT04838496
What this trial is testing

Induction Chemotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Catharina Ziekenhuis Eindhoven 128
Not applicableUnknownNCT04440605
What this trial is testing

Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis

Who this might be right for
Gastric CancerGastric Cancer StageCT+1 more
Peking University 968
Not applicableLooking for participantsNCT06193356
What this trial is testing

Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable

Who this might be right for
Colorectal PolypColorectal Cancer
University Hospital, Ghent 141
Not applicableStudy completedNCT02088775
What this trial is testing

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more
Fox Chase Cancer Center 44
Next Page